---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-25-000039"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T02:58:31.298511+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# West Pharmaceutical shareholders approve all proposals at 2025 annual meeting; adopt special meeting right

## Summary
- Shareholders elected all 12 director nominees; highest vote against was Deborah Keller (7.4M against).
- Advisory vote on executive compensation approved with 59.2M for, 3.5M against (91.4% support).
- Articles amended to allow shareholders to call special meetings, approved with 62.7M for (99.9% for).
- 2016 Omnibus Incentive Compensation Plan amended and restated, approved with 60.9M for (97.0% for).
- PricewaterhouseCoopers ratified as auditor for 2025 with 60.5M for, 4.4M against.

## SEC filing metadata
- accession: 0000105770-25-000039
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577025000039/0000105770-25-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577025000039/wst-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-25-000039
- JSON: https://secwatch.observer/filing/0000105770-25-000039.json
- Plain text: https://secwatch.observer/filing/0000105770-25-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.